首页> 外文期刊>Diabetes >Circulating Triacylglycerol Signatures in Nonalcoholic Fatty Liver Disease Associated With the I148M Variant in PNPLA3 and With Obesity
【24h】

Circulating Triacylglycerol Signatures in Nonalcoholic Fatty Liver Disease Associated With the I148M Variant in PNPLA3 and With Obesity

机译:非酒精性脂肪性肝病中循环三酰基甘油信号与PNPLA3和肥胖症的I148M变异相关

获取原文
获取原文并翻译 | 示例
       

摘要

We examined whether relative concentrations of circulating triacylglycerols (TAGs) between carriers compared with noncarriers of PNPLA3~(I148M) gene variant display deficiency of TAGs, which accumulate in the liver because of defective lipase activity. We also analyzed the effects of obesity-associated nonalcoholic fatty liver disease (NAFLD) independent of genotype, and of NAFLD due to either PNPLA3~(I148M) gene variant or obesity on circulating TAGs. A total of 372 subjects were divided into groups based on PNPLA3 genotype or obesity. Absolute and relative deficiency of distinct circulating TAGs was observed in the pnplA3~(148MM/148MI) compared with the PNPLA3~(148II) group. Obese and 'nonobese' groups had similar PNPLA3 genotypes, but the obese subjects were insulin-resistant. Liver fat was similarly increased in obese and pnplA3~(148MM/148MI) groups. Relative concentrations of TAGs in the obese subjects versus nonobese displayed multiple changes. These closely resembled those between obese subjects with NAFLD but without PNPLA3~(I148M) versus those with the I148M variant and NAFLD. The etiology of NAFLD influences circulating TAG profiles. 'PNPLA3 NAFLD' is associated with a relative deficiency of TAGs, supporting the idea that the I148M variant impedes intrahepatocellular lipolysis rather than stimulates TAG synthesis. 'Obese NAFLD' is associated with multiple changes in TAGs, which can be attributed to obesity/insulin resistance rather than increased liver fat content per se.
机译:我们检查了携带者之间的循环三酰甘油(TAG)相对浓度与非携带者PNPLA3〜(I148M)基因变体的相对浓度是否显示出TAG不足,这些脂肪由于脂肪酶活性缺陷而在肝脏中积累。我们还分析了肥胖相关的非酒精性脂肪肝疾病(NAFLD)的影响,其与基因型无关,以及由于PNPLA3〜(I148M)基因变异或肥胖对循环TAGs的影响。共有372位受试者根据PNPLA3基因型或肥胖症分为两组。与PNPLA3〜(148II)组相比,在pnplA3〜(148MM / 148MI)中观察到不同循环TAG的绝对和相对缺乏。肥胖和“非肥胖”组具有相似的PNPLA3基因型,但肥胖受试者具有胰岛素抵抗性。肥胖组和pnplA3〜(148MM / 148MI)组的肝脏脂肪含量也相似。肥胖受试者与非肥胖受试者中TAG的相对浓度显示出多种变化。这些与患有NAFLD但没有PNPLA3〜(I148M)的肥胖受试者与具有I148M变体和NAFLD的肥胖受试者之间的相似。 NAFLD的病因会影响循环TAG谱。 'PNPLA3 NAFLD'与TAG的相对缺乏有关,支持了I148M变体阻碍肝细胞内脂解而不是刺激TAG合成的想法。 “肥胖NAFLD”与TAGs的多种变化有关,这可以归因于肥胖/胰岛素抵抗,而不是肝脏脂肪本身的增加。

著录项

  • 来源
    《Diabetes》 |2014年第1期|312-322|共11页
  • 作者单位

    Department of Medicine, University of Helsinki, Helsinki, Finland,Minerva Foundation Institute for Medical Research, Helsinki, Finland;

    VTT Technical Research Centre of Finland, Espoo, Finland;

    Minerva Foundation Institute for Medical Research, Helsinki, Finland;

    VTT Technical Research Centre of Finland, Espoo, Finland;

    Department of Surgery, Helsinki University Central Hospital, Vantaa, Finland;

    Department of Surgery, Helsinki University Central Hospital, Vantaa, Finland;

    Department of Surgery, Helsinki University Central Hospital, Vantaa, Finland;

    Turku PET Centre, University of Turku, Turku, Finland;

    Turku PET Centre, University of Turku, Turku, Finland;

    Minerva Foundation Institute for Medical Research, Helsinki, Finland;

    VTT Technical Research Centre of Finland, Espoo, Finland;

    Department of Medicine, University of Helsinki, Helsinki, Finland,Minerva Foundation Institute for Medical Research, Helsinki, Finland;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:18

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号